Olanzapine effects on emotional recognition in treatment refractory schizophrenics;Efectos de la olanzapina sobre el reconocimiento emocional en pacientes esquizofrenicos refractarios al tratamiento

Actas Espanolas de Psiquiatria

Volumn 31, Issue 5, 2003, Pages 256-262

  Ibarraran Pernas, G Y ^a   Cerdan, L E ^b   Guevara, M A ^a   Ramos Loyo, Julieta ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Refractory schizophrenia. Olanzapine. Emotional recognition. Depression.

Indexed keywords

BENZODIAZEPINE DERIVATIVE; OLANZAPINE;

ADULT; AFFECT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; DRUG EFFECT; FEMALE; HUMAN; MALE; QUESTIONNAIRE; RECOGNITION; SCHIZOPHRENIA;

ADULT; AFFECT; BENZODIAZEPINES; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HUMANS; MALE; QUESTIONNAIRES; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA;

EID: 1542541377     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Mueser KT, Doonan R, Penn DL, Blanchard JJ, Bellack AS, Nishith P, et al. Emotion recognition and social competence in chronic schizophrenia. J Abnorm Psychol 1996; 105:2271-2275
2. Flack WF, Laird JD, Cavallaro LA. Emotional expression and feeling in schizophrenia: effects of specific expressive behaviors on emotional experiences. J Clin Psychol 1999; 55:11-20.
3. Garrido-Casas G. Especialización hemisférica y procesos emocionales en pacientes esquizofrénicos y depresivos (tesis de doctorado). Espafia: Universidad Autónoma de Madrid, 1997.
4. Kington LA, Jones LA, Hopkin EJ. Impaired eye expression recognition in schizophrenia. J Psychiatric Res 2000; 34: 314-347
5. Schneider F, Gur RC, Gur RE, Shtasel DL. Emotional processing in schizophrenia: neurobehavioral in relation to psychopathology. Schizophr Res 1995;17:167-175
6. Walker E, McGuire M, Bettes B. Recognition and identification of facial stimuli by schizophrenics and patients with affective disorders. Br J Clin Psychol 1984;23:37-44.
7. Edwards J, Pattison P, Jackson H, Wales R. Facial affect and affective prosody recognition in first-episode schizophrenia. Schizophr Res 2001;48:235-253
8. Poole J, Tobias F, Vinogradov S. The functional relevance of affect recognition error in schizophrenia. J Int Neu-ropsy Soc 2000;6:649-658
9. Kring AM, Neale JM. Flat affect in schizophrenia does not reflect diminished subjective experience of emotion. J Abnorm Psychol 1993;102:507-517
10. Kring AM, Neale JM. Do schizophrenic patients show a disjunctive relationship among expressive, experiential and psychophysiological components of emotion? J Abnorm Psychol 1996;102:249-257
11. Cuesta MJ, Peralta V, Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 2001; 48:17-28.
12. Purdon SE, Jones B, Stip E, Labelle A, Addington D, David S, et al. Cognitive improvement in schizophrenia with novel antipsychotic medications. Schizophr Res 1999;35: 551-560
13. 13- Kce KS, Kern R, Green M. Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminay findings. Schizophr Res 1998;31:159-165
14. ToIIefson G, Beasley C, Tran P, Street J, Krueger JA, Tamu-ra J, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreni-form disorders: results of an international collaborative trial. Am J Psychiatry 1997;154:457-465
15. Purdon SE. Measuring neuropsychological change in schizophrenia with novel antipsychotic medications. Schizophr Res 2000;25:108-116
16. Romera MI, Gurpegui M. Procesamiento visuoperceptivo en los pacientes con esquizofrenia tratados con antipsicóticos típicos y los tratados con atípicos. Actas Esp Psiquiatr 2001;29:19-24.
17. Tollefson GD, Sanger TM, Beasley CM, Iran PV. A double-blind, controlled comparison of the novel antipsychotic olanzapina versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. Soc Biol Psychiatry 1998;43:803-810
18. Brenner HD, Merlo MCG. Definition of therapy resistant schizophrenia and its assessment. Eur Psychiatry 1995;10:11-18
19. Ramos J, Cerdán LF, Guevara MA, Amezcua C. Alteraciones en la atención y el reconocimiento de emociones faciales en esquizofrénicos refractarios y no refractarios al trata-miento, evaluadas a través de un paradigma odd-ball. Rev Neurol 2001;11:1027-1032
20. Joober R, Randolph C, Green M. Neuropsychological impairments in neuroleptic-responder vs. non-responder schizophrenic patients and healthy volunteers. Schizophr Res 2002;53:229-238
21. Ramos J, Cerdán LF, Guevara MA, Amezcua C, Sanz A. Abnormal EEG patterns in treatment-resistant schizophrenic patients. Int J Neurosci 2001;109:47-59.
22. Asociación Psiquiátrica Americana. Manual diagnóstico y estadístico de los trastornos mentales DSM-PV. Barcelona: Masson, 1995.
23. Organización mundial de la salud. CIE 10. Trastornos men-tales y del comportamiento. Madrid: Meditor, 1992.
24. Overall JE. Brief psychiatric rating scale. Psychol Reports 1962;10:799-812.
25. Kay SR, Opler LA, Fiszbein A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
26. Keefe R, Mohs R, Silverman JM. Characteristics of Kraepe-linian schizophrenia and their relation to premorbid social functioning. En: Angrist BO, Shultz CH, editores. The neuroleptic non responsive patient: characterization and treatment. Washington: American Psychiatric Press, 1990.
27. Annet M. The binomial distribution of right, mixed and left handedness. Q J Exp Psychol 1967;61:303-321
28. Addington D, Addington J, Maticka-Tyndale E. Rating depression in schizophrenia. J NervMent Dis 1993;181:561-565
29. Ekman P, Sorenson ER, Friesen W. Pancultural elements in facial displays of emotion. Science 1969;164:86-88
30. Kohler CG, Bilker W, Hagendoorn M, Gur E, Gur RC. Emotion recognition deficit in schizophrenia: association with symptomathology and cognition. Biol Psychiatry 2000; 48(2):127-136
31. Shaw RJ, Ringo DL, Dong M, Lim KO. Recognition of facial expression and emotional prosody in schizophrenia. Biol Psychiatry 1996;39(7):578.
32. Shaw RJ, Dong M, Lim KO, Faustman WO, Pouget ER, Alpert M. The relationship between affect expression and effect recognition in schizophrenia. Schizophr Res 1999; 37:245-250
33. Westerink BHC, Kawahara Y, de Boer P. Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Eur J Pharmacol 2001;412:127-138
34. Zhang W, Perry K, Wong D, Potts B, Bao J, Tollefson GD, et al. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology 2000;23:250-262
35. Grace, AA. Gating of information flow Within the limbic system and the patophysiology of schizophrenia. Brain Res Rev 1999;31:330-341
36. Pérez-Rincón H, Cortés J, Díaz- Martínez A. El reconoci-miento de la expresión facial de las emociones. Salud Mental 1999;22:17-23.
37. Allen D, Goldstein G, Weiner C. Differential neuropsychological patterns of frontal and temporal lobe dysfunction in patients with schizoprhrenia. Schizophr Res 2001;48: 7-15.
38. Devinsky O, Morrell M Vogt B. Contributions of anterior cingulated cortex to behavior. Brain 1995;118:279-306.
39. Gur RE, McGrath C, Chan RM, Schoeder L, Turner T, Tu-retsky BI, et al. An fMRI study of facial emotion processing in patients with schizophrenia. Am J Psychiatry 2002; 159:1992-1999
40. Kosaka H, Omori M, Murata T, Iidaka T, Yamada H, Okada T, et al. Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study. Schizophr Res 2002;57:87-95.
41. Taylor SF, Liberzon I, Decker LR, Koeppe R. A functional anatomic study of emotion in schizophrenia. Schizophr Res 2002;58:159-172
42. Frangou S, Murray R. Schizophrenia. London: Martin Du-nitz Ltd, 1996.